MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
547.89
-2.98
-0.54%
After Hours: 549.00 +1.11 +0.20% 19:02 11/10 EST
OPEN
546.97
PREV CLOSE
550.87
HIGH
551.86
LOW
543.44
VOLUME
1.24M
TURNOVER
--
52 WEEK HIGH
568.67
52 WEEK LOW
410.50
MARKET CAP
138.91B
P/E (TTM)
35.25
1D
5D
1M
3M
1Y
5Y
1D
Crispr Therapeutics: The Recent 40% Drop In Short Interest Indicates Deteriorating Bearish Sentiment
Seeking Alpha · 11h ago
3 Biotech Stocks To Watch As US Policy Support Comes Into Focus
Simply Wall St · 21h ago
How Raised Revenue Guidance At Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story
Simply Wall St · 1d ago
Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain?
Benzinga · 1d ago
Weekly Report: what happened at VRTX last week (1102-1106)?
Weekly Report · 1d ago
Vertex Earnings Call Signals Broad-Based Growth Ahead
TipRanks · 2d ago
The Top 5 Biotech Stocks I'd Buy Right Now Without Any Hesitation
The Motley Fool · 2d ago
Vertex Pharmaceuticals (VRTX) Lifts Revenue Guidance, Is It Still A Bargain?
Simply Wall St · 2d ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The Company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, acute pain and acromegaly, and it continues to advance clinical and research programs in these areas. It also has a clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, congenital adrenal hyperplasia, ACTH-dependent Cushing's syndrome, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1. The Company's pipeline also includes PALSONIFY (paltusotine) and atumelnant. PALSONIFY is the once-daily oral therapy for acromegaly.

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.